IBDEI02U ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,785,0)
 ;;=L60.0^^3^32^51
 ;;^UTILITY(U,$J,358.3,785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,785,1,3,0)
 ;;=3^Ingrowing nail
 ;;^UTILITY(U,$J,358.3,785,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,785,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,786,0)
 ;;=L60.2^^3^32^117
 ;;^UTILITY(U,$J,358.3,786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,786,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,786,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,786,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,787,0)
 ;;=L60.1^^3^32^118
 ;;^UTILITY(U,$J,358.3,787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,787,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,787,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,787,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,788,0)
 ;;=L60.3^^3^32^55
 ;;^UTILITY(U,$J,358.3,788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,788,1,3,0)
 ;;=3^Nail dystrophy
 ;;^UTILITY(U,$J,358.3,788,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,788,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,789,0)
 ;;=L65.9^^3^32^116
 ;;^UTILITY(U,$J,358.3,789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,789,1,3,0)
 ;;=3^Nonscarring hair loss, unspecified
 ;;^UTILITY(U,$J,358.3,789,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,789,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,790,0)
 ;;=L73.9^^3^32^42
 ;;^UTILITY(U,$J,358.3,790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,790,1,3,0)
 ;;=3^Follicular disorder, unspecified
 ;;^UTILITY(U,$J,358.3,790,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,790,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,791,0)
 ;;=L30.1^^3^32^34
 ;;^UTILITY(U,$J,358.3,791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,791,1,3,0)
 ;;=3^Dyshidrosis [pompholyx]
 ;;^UTILITY(U,$J,358.3,791,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,791,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,792,0)
 ;;=L73.2^^3^32^49
 ;;^UTILITY(U,$J,358.3,792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,792,1,3,0)
 ;;=3^Hidradenitis suppurativa
 ;;^UTILITY(U,$J,358.3,792,1,4,0)
 ;;=4^L73.2
 ;;^UTILITY(U,$J,358.3,792,2)
 ;;=^278979
 ;;^UTILITY(U,$J,358.3,793,0)
 ;;=L70.0^^3^32^1
 ;;^UTILITY(U,$J,358.3,793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,793,1,3,0)
 ;;=3^Acne vulgaris
 ;;^UTILITY(U,$J,358.3,793,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,793,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,794,0)
 ;;=L72.3^^3^32^137
 ;;^UTILITY(U,$J,358.3,794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,794,1,3,0)
 ;;=3^Sebaceous cyst
 ;;^UTILITY(U,$J,358.3,794,1,4,0)
 ;;=4^L72.3
 ;;^UTILITY(U,$J,358.3,794,2)
 ;;=^5009281
 ;;^UTILITY(U,$J,358.3,795,0)
 ;;=L97.929^^3^32^57
 ;;^UTILITY(U,$J,358.3,795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,795,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of l low leg w unsp severity
 ;;^UTILITY(U,$J,358.3,795,1,4,0)
 ;;=4^L97.929
 ;;^UTILITY(U,$J,358.3,795,2)
 ;;=^5133689
 ;;^UTILITY(U,$J,358.3,796,0)
 ;;=L97.922^^3^32^58
 ;;^UTILITY(U,$J,358.3,796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,796,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of l low leg w fat layer exposed
 ;;^UTILITY(U,$J,358.3,796,1,4,0)
 ;;=4^L97.922
 ;;^UTILITY(U,$J,358.3,796,2)
 ;;=^5133682
 ;;^UTILITY(U,$J,358.3,797,0)
 ;;=L97.923^^3^32^59
 ;;^UTILITY(U,$J,358.3,797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,797,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of l low leg w necros muscle
 ;;^UTILITY(U,$J,358.3,797,1,4,0)
 ;;=4^L97.923
 ;;^UTILITY(U,$J,358.3,797,2)
 ;;=^5133684
 ;;^UTILITY(U,$J,358.3,798,0)
 ;;=L97.924^^3^32^60
 ;;^UTILITY(U,$J,358.3,798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,798,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of l low leg w necrosis of bone
 ;;^UTILITY(U,$J,358.3,798,1,4,0)
 ;;=4^L97.924
 ;;
 ;;$END ROU IBDEI02U
